Click it and Unblock the Notifications
For Quick Alerts
For Daily Alerts
Just In
Don't Miss
-
Olympic Selection Trials: Ashi-Swapnil Shine In 3-Position Shooting -
Mirzapur 3 OTT Release Date, Platform: When Will Mirzapur Season 3 Premiere On Amazon Prime Video? -
25% Dividend Record Date: Logistic Stock Nears 1-Year High And It Belongs To Mahindra; Motilal Neutral -
Telangana Inter Manabadi 1st and 2nd Year Results 2024 to be Declared Tomorrow -
Chrysler Pacifica Marks Seven Years As Most Awarded Minivan With New Campaign -
Anant Ambani-Radhika Merchant's Wedding Function Details Are Out, Check out Ambani Bahu-To-Be's Chic Fashion! -
Xiaomi Robot Vacuum Cleaner S10, Handheld Garment Steamer, and Redmi Buds 5A Launched in India -
Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Drug for increasing platelet counts in dengue patients
Coimbatore, Mar 8: A medicine has been launched for the treatment of dengue patients with low platelet counts by the Karnataka Antibiotics and Pharmaceuticals Limited (KAPL), a government enterprise.
The drug, POP–e, contains papaya leaf extracts (carica papaya leaf extract) in the form of a tablet and is available at a strength of 1100 mg, a KAPL release said here.
KAPL, engaged in manufacturing and marketing of life saving quality drugs, said POP-e was a time-tested economical medicine for the treatment of dengue. It would be available on doctors' prescription from tomorrow in Tamil Nadu and Kerala, the release said.
PTI
Comments
